Filed: 8/14/2023ACC: 0001389933-23-000008
📋 What this filing means
DAFNA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 73 equity positions with a total reported market value of $365.73M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
73
Positions
$365.73M
Total AUM (reported)
43.47M
Total Shares
Allocation by class
COM$233.89M64.0%
ETF$60.02M16.4%
COM NEW$35.32M9.7%
SPONSORED ADR$12.07M3.3%
COMMON STOCK$6.02M1.6%
SPONSORED ADS$4.27M1.2%
NOTE 2.250% 4/0$3.63M1.0%
Portfolio Concentration
Top 3$92.05M25.2%
4–10$88.66M24.2%
11–25$107.47M29.4%
Rest$77.55M21.2%
Top 3 weight
25.2%
Top 10 weight
49.4%
Voting Authority Distribution
Total shares with voting rights: 43.47M
Sole
Full voting authority
43.47M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole73
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings73
Rows:
SPDR S&P BIOTECH ETF
SOLEShares565K
TypeSH
Market value$47.01M
12.85%
Sole
565K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares612.98K
TypeSH
Market value$24.11M
6.59%
Sole
612.98K
Shared
0.00
None
0.00
STEREOTAXIS INC
SOLEShares13.68M
TypeSH
Market value$20.93M
5.72%
Sole
13.68M
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares251.52K
TypeSH
Market value$15.90M
4.35%
Sole
251.52K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares512.28K
TypeSH
Market value$13.70M
3.75%
Sole
512.28K
Shared
0.00
None
0.00
ISHARES NASDAQ BIOTECH INDX
SOLEShares102.50K
TypeSH
Market value$13.01M
3.56%
Sole
102.50K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares135.21K
TypeSH
Market value$12.07M
3.30%
Sole
135.21K
Shared
0.00
None
0.00
MORPHIC HOLDING INC
SOLEShares206.75K
TypeSH
Market value$11.85M
3.24%
Sole
206.75K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares479.82K
TypeSH
Market value$11.28M
3.08%
Sole
479.82K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares332.73K
TypeSH
Market value$10.85M
2.97%
Sole
332.73K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares280.54K
TypeSH
Market value$10.80M
2.95%
Sole
280.54K
Shared
0.00
None
0.00
MERUS N V
SOLEShares384.87K
TypeSH
Market value$10.13M
2.77%
Sole
384.87K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares450.87K
TypeSH
Market value$9.44M
2.58%
Sole
450.87K
Shared
0.00
None
0.00
KARUNA THERAPEUTICS INC
SOLEShares42.17K
TypeSH
Market value$9.15M
2.50%
Sole
42.17K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares67.55K
TypeSH
Market value$8.68M
2.37%
Sole
67.55K
Shared
0.00
None
0.00
SAGE THERAPEUTICS INC
SOLEShares180.31K
TypeSH
Market value$8.48M
2.32%
Sole
180.31K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares74.61K
TypeSH
Market value$7.04M
1.92%
Sole
74.61K
Shared
0.00
None
0.00
ATRICURE INC
SOLEShares125.53K
TypeSH
Market value$6.20M
1.69%
Sole
125.53K
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares507.10K
TypeSH
Market value$6.05M
1.66%
Sole
507.10K
Shared
0.00
None
0.00
DICE THERAPEUTICS INC
SOLEShares127.58K
TypeSH
Market value$5.93M
1.62%
Sole
127.58K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares556.70K
TypeSH
Market value$5.56M
1.52%
Sole
556.70K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares611.03K
TypeSH
Market value$5.50M
1.50%
Sole
611.03K
Shared
0.00
None
0.00
2SEVENTY BIO INC
SOLEShares496.42K
TypeSH
Market value$5.02M
1.37%
Sole
496.42K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares293.65K
TypeSH
Market value$4.76M
1.30%
Sole
293.65K
Shared
0.00
None
0.00
ACCURAY INC
SOLEShares1.22M
TypeSH
Market value$4.73M
1.29%
Sole
1.22M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P BIOTECH ETFSOLE | ETF | 565K | SH | $47.01M 12.85% | 565K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 612.98K | SH | $24.11M 6.59% | 612.98K | 0.00 | 0.00 |
STEREOTAXIS INCSOLE | COM NEW | 13.68M | SH | $20.93M 5.72% | 13.68M | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 251.52K | SH | $15.90M 4.35% | 251.52K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 512.28K | SH | $13.70M 3.75% | 512.28K | 0.00 | 0.00 |
ISHARES NASDAQ BIOTECH INDXSOLE | ETF | 102.50K | SH | $13.01M 3.56% | 102.50K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 135.21K | SH | $12.07M 3.30% | 135.21K | 0.00 | 0.00 |
MORPHIC HOLDING INCSOLE | COM | 206.75K | SH | $11.85M 3.24% | 206.75K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 479.82K | SH | $11.28M 3.08% | 479.82K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 332.73K | SH | $10.85M 2.97% | 332.73K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 280.54K | SH | $10.80M 2.95% | 280.54K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 384.87K | SH | $10.13M 2.77% | 384.87K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 450.87K | SH | $9.44M 2.58% | 450.87K | 0.00 | 0.00 |
KARUNA THERAPEUTICS INCSOLE | COM | 42.17K | SH | $9.15M 2.50% | 42.17K | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 67.55K | SH | $8.68M 2.37% | 67.55K | 0.00 | 0.00 |
SAGE THERAPEUTICS INCSOLE | COM | 180.31K | SH | $8.48M 2.32% | 180.31K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 74.61K | SH | $7.04M 1.92% | 74.61K | 0.00 | 0.00 |
ATRICURE INCSOLE | COM | 125.53K | SH | $6.20M 1.69% | 125.53K | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 507.10K | SH | $6.05M 1.66% | 507.10K | 0.00 | 0.00 |
DICE THERAPEUTICS INCSOLE | COM | 127.58K | SH | $5.93M 1.62% | 127.58K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 556.70K | SH | $5.56M 1.52% | 556.70K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 611.03K | SH | $5.50M 1.50% | 611.03K | 0.00 | 0.00 |
2SEVENTY BIO INCSOLE | COMMON STOCK | 496.42K | SH | $5.02M 1.37% | 496.42K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 293.65K | SH | $4.76M 1.30% | 293.65K | 0.00 | 0.00 |
ACCURAY INCSOLE | COM | 1.22M | SH | $4.73M 1.29% | 1.22M | 0.00 | 0.00 |
Page 1 of 3